X4 Pharmaceuticals, Inc. (XFOR) Profit Margin
X4 Pharmaceuticals, Inc. (XFOR) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2018-12-31 | -1036.71% |
| 2019-12-31 | -377192.86% |
| 2020-12-31 | -2071.03% |
| 2021-12-31 | -45253.06% |
| 2022-12-31 | -47891.33% |
| 2023-12-31 | -51880.51% |
| 2024-12-31 | -1464.61% |
| 2025-12-31 | -225.55% |
How XFOR compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| MRNA | Moderna Inc. | -145.16% |
| VERU | Veru Inc. | -223.86% |
| DYAI | Dyadic International Inc. | -238.31% |
| VYGR | Voyager Therapeutics Inc. | -296.53% |
| NKTR | Nektar Therapeutics | -297.07% |
These are five companies in the same sector as XFOR with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get X4 Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("XFOR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XFOR | $4.22 | +0.00% | 1.13M |
| 3 | ||||
| 4 | ||||
| 5 |